hrc
prepar
ribavirin
shenzen
china
salin
pb
phosphoryl
group
accord
establish
subsequ
activ
phosphorimidazolid
accord
method
fium
et
react
excess
human
carbonmonoxyhemoglobin
hemosol
corp
mississauga
ontario
canada
moll
sodium
bicarbon
buffer
ph
result
phosphoramid
attach
protein
amino
group
molar
drug
ratio
conjug
determin
ribavirin
molecul
per
hemoglobin
littl
unmodifi
hemoglobin
remain
hour
reaction
conjug
extens
dialyz
pb
complet
reaction
purifi
rat
haptoglobin
incub
pb
form
hrc
complex
subsequ
purifi
prepar
asept
chromatographi
remov
unbound
final
product
diafilt
pb
concentr
mgml
total
protein
obtain
american
type
cultur
collect
rockvil
md
plaqu
purifi
monolay
dbtcell
grown
titer
unit
pfu
ml
cell
viru
harvest
centrifug
hour
assay
monolay
cell
standard
plaqu
assay
periton
macrophag
harvest
balbcj
mice
day
intraperiton
inject
ml
thioglycol
difco
laboratori
detroit
mi
macrophag
rpmi
icn
biomed
costa
mesa
ca
supplement
mmoll
glutamin
sigma
chemic
st
loui
mo
fb
flow
laboratori
mississauga
ontario
canada
macrophag
pure
determin
morpholog
esteras
stain
viabil
exceed
trypan
blue
exclus
hepatocyt
isol
liver
balbcj
mice
previous
briefli
mice
anesthet
intraperiton
inject
pentobarbit
g
bodi
weight
abdomen
open
midlin
incis
portal
vein
expos
cannul
silast
tube
liver
perfus
oxygen
hank
balanc
salt
solut
hbss
flow
rate
mlmin
minut
perfus
chang
hbss
calcium
magnesium
collagenas
b
dnase
minut
liver
remov
place
steril
petri
dish
contain
cold
hbss
fb
liver
cell
dispers
cellular
suspens
centrifug
minut
twice
cell
pellet
ml
hbss
centrifug
minut
cell
count
concentr
complet
rpmi
fortifi
fb
viabil
hepatocyt
assess
trypan
blue
stain
puriti
hepatocyt
judg
absenc
immunofluoresc
stain
macrophageskupff
cell
endotheli
cell
immunofluoresc
posit
mhc
class
ii
mous
periton
macrophag
isol
balbcj
mice
outlin
previous
cell
presenc
hrc
conjug
ribavirin
free
ribavirin
hour
infect
pfu
moi
macrophag
harvest
hour
infect
analyz
viral
titer
describ
hepatocyt
isol
balbcj
mice
presenc
increas
concentr
either
hrc
ribavirin
hour
medium
replac
fresh
medium
follow
infect
moi
period
hour
cell
harvest
measur
viral
titer
carri
manner
similar
describ
macrophag
mous
periton
macrophag
isol
balbcj
mice
outlin
previous
cell
place
ml
polypropylen
tube
complex
prepar
fresh
assay
combin
haptoglobin
fhp
hb
molar
ratio
incub
hour
room
temperatur
rt
dark
two
aliquot
dilut
rmpi
fb
ad
macrophag
incub
hour
cell
pellet
rpm
minut
wash
pb
macrophag
either
moi
rmpi
fb
hour
dexamethason
rmpi
fb
hour
control
rmpi
fb
cell
wash
rpmi
fb
place
hour
incub
compound
hour
bind
fluoresc
label
protein
macrophag
detect
use
cytom
fc
mpl
flow
cytomet
analyz
cytometr
rxp
analysi
softwar
beckman
coulter
fullerton
ca
supernat
collect
treat
cell
concentr
assay
elisa
monoclon
hamster
ab
genzym
boston
coat
elisa
plate
overnight
wash
tri
buffer
ph
plate
block
bovin
serum
albumin
well
hour
rt
wash
standard
sampl
ad
incub
rt
hour
subsequ
polyclon
rabbit
ab
genzym
ad
well
plate
incub
overnight
goat
igg
alkalin
phosphatas
jackson
immunoresearch
laboratori
west
grove
pa
ad
plate
incub
rt
hour
wash
diflusin
phosphat
substrat
buffer
ad
plate
incub
addit
minut
rt
shake
plate
read
cyber
fluor
beckman
instrument
fullerton
ca
unit
assay
comparison
mous
standard
genzym
supernat
collect
treat
cell
concentr
assay
abil
supernat
inhibit
support
prolifer
wehi
cell
cultur
incub
hour
humidifi
atmospher
puls
h
thymidin
sp
act
cimmol
amersham
arlington
height
il
harvest
hour
later
onto
glass
fiber
filter
total
radioact
measur
beckman
scintil
counter
bioassay
data
express
nanogramsmillilit
deriv
standard
curv
mous
recombin
genzym
femal
balbcj
mice
week
age
purchas
charl
river
laboratori
st
constant
quebec
canada
hous
cage
anim
facil
toronto
gener
hospit
mice
fed
standard
laboratori
chow
diet
water
ad
libitum
anim
divid
treatment
group
n
mice
per
group
group
control
pfumous
group
receiv
hrc
via
tail
vein
inject
mg
conjug
ribavirinkgday
start
day
daili
thereaft
pfumous
group
receiv
ribavirin
tail
vein
inject
describ
sidwel
et
mgkgday
start
day
daili
thereaft
pfumous
group
control
uninfect
mice
control
anim
given
daili
inject
pb
via
tail
vein
mice
infect
intraperiton
inject
unit
pfu
pb
mice
kill
day
analyz
evid
hepat
liver
biochemistri
alanin
transaminas
alt
hematolog
disturb
hemoglobin
hematocrit
white
blood
cell
count
platelet
count
renal
dysfunct
blood
urea
nitrogen
effect
treatment
ribavirin
hrc
liver
diseas
determin
monitor
mice
twice
daili
subject
sign
clinic
behavior
includ
abnorm
fur
textur
decreas
activ
increas
respir
presenc
tremor
develop
decreas
activ
increas
fur
ruffl
difficulti
respir
increas
shake
sign
poor
clinic
behavior
grade
scale
indic
mark
presenc
abnorm
normal
composit
score
paramet
calcul
perform
independ
examin
blind
treatment
regimen
attempt
minim
bia
day
sacrific
mice
anesthet
use
halothan
follow
percutan
cardiac
punctur
collect
blood
microtain
tube
franklin
lake
nj
previous
liver
remov
time
death
describ
follow
section
effect
ribavirin
hrc
viral
replic
vivo
vitro
studi
determin
standard
plaqu
assay
vitro
studi
monolay
periton
macrophag
hepatocyt
balbcj
mice
pretreat
ribavirin
hrc
medium
rpmi
addit
viru
moi
hour
post
infect
cell
harvest
subject
one
cycl
freez
thaw
assay
viral
titer
monolay
cell
vivo
studi
section
liver
tissu
weigh
snap
frozen
tissu
collect
analysi
subsequ
tissu
thaw
homogen
dounc
homogen
dulbecco
modifi
essenti
medium
supplement
fb
mmoll
glutamin
homogen
assay
viru
use
plaqu
assay
describ
previous
free
hb
shown
hepatocyt
macrophag
toxic
viral
inhibitori
effect
concentr
studi
data
shown
time
sacrific
liver
remov
weigh
fix
buffer
formalin
minimum
hour
tissu
process
routin
methodolog
section
thick
stain
hematoxylin
eosin
martiu
scarlet
addit
liver
immunostain
fibrin
use
nex
immunostain
section
liver
recov
mice
per
group
time
point
score
extent
necrosi
fibrin
deposit
surfac
liver
examin
equal
instanc
correspond
contigu
histolog
field
low
magnif
blood
analyz
hemoglobin
hematocrit
prothrombin
time
partial
thromboplastin
time
use
portabl
hemochron
jr
ii
microcoagul
system
intern
technidyn
corpor
edison
nj
sera
anim
analyz
quantit
measur
liver
cell
necrosi
serum
alt
univers
health
network
central
laboratori
previous
blood
sugar
electrolyt
blood
urea
nitrogen
analyz
sampl
use
ektachem
analyz
depart
biochemistri
univers
health
network
previous
lack
interfer
biochemistri
test
address
includ
sampl
normal
sera
spike
differ
concentr
conjug
complex
unus
sera
frozen
store
addit
test
requir
statist
analysi
conduct
student
test
p
valu
less
consid
statist
signific
result
report
mean
sd
least
separ
experi
perform
triplic
previou
report
suggest
infect
mediat
viral
replic
macrophag
replic
therefor
experi
perform
examin
efficaci
hrc
directli
viral
replic
isol
macrophag
cell
either
pb
control
free
ribavirin
hrc
conjug
ribavirin
hour
infect
viru
concentr
ribavirin
chosen
base
previou
report
effect
ribavirin
viral
replic
isol
macrophag
cultur
respons
curv
cell
harvest
hour
viral
titer
measur
describ
previous
ad
concentr
free
ribavirin
effect
reduc
viral
titer
contrast
lower
dose
ribavirin
conjug
hb
inhibit
replic
fig
degre
inhibit
signific
repres
approxim
decreas
viral
titer
log
compar
cell
fig
inhibit
respons
hrc
attribut
toxic
effect
cell
demonstr
trypan
blue
exclus
data
shown
strike
effect
hrc
viral
replic
may
attribut
target
deliveri
hrc
via
receptor
locat
surfac
cell
monocytemacrophag
lineag
previou
studi
shown
express
increas
respons
glucocorticoid
dexamethason
measur
macrophag
cultur
periton
macrophag
bind
compar
macrophag
fig
bind
increas
fashion
case
howev
bind
tend
greater
macrophag
data
consist
previou
report
dexamethason
induc
express
surfac
experi
perform
test
abil
hrc
modul
immun
respons
macrophag
ribavirin
shown
alter
product
cytokin
mous
periton
supernat
macrophag
analyz
product
cytokin
macrophag
produc
significantli
higher
level
respons
infect
comparison
basal
valu
fig
ribavirin
hrc
conjug
ribavirin
significantli
inhibit
product
macrophag
compar
control
compound
prevent
increas
cytokin
level
baselin
howev
effect
achiev
use
much
lower
dose
ribavirin
hrc
conjug
form
free
ribavirin
form
experi
perform
examin
efficaci
hrc
directli
viral
replic
isol
hepatocyt
hepatocyt
isol
balbcj
mice
presenc
increas
concentr
either
hrc
ribavirin
hour
incub
cell
wash
time
remov
unbound
hrc
ribavirin
infect
kept
cultur
hour
result
experi
suggest
hrc
effect
free
ribavirin
inhibit
viral
replic
fig
inhibit
viral
replic
hrc
approxim
conjug
ribavirin
compar
inhibit
concentr
free
ribavirin
inhibit
hrc
free
ribavirin
similar
drug
higher
anoth
measur
improv
efficaci
abil
hrc
inhibit
cytopath
effect
viru
indic
format
hepat
cell
fusion
syncytia
respons
viral
infect
fig
compar
normal
uninfect
hepatocyt
fig
untreat
hepatocyt
develop
patholog
condit
evidenc
presenc
syncytia
within
hour
infect
fig
pretreat
hepatocyt
hrc
result
mark
reduct
patholog
condit
fig
contrast
concentr
free
ribavirin
effect
reduc
format
syncytia
macrophag
fig
result
vitro
studi
demonstr
improv
efficaci
hrc
free
ribavirin
therefor
seri
experi
perform
evalu
vivo
efficaci
hrc
cours
fulmin
hepat
failur
induc
suscept
balbcj
mice
balbcj
mice
infect
viru
treat
pb
free
ribavirin
hrc
treatment
mice
examin
daili
effect
surviv
clinic
behavior
one
mous
untreat
group
mice
ribavirin
hrc
group
sacrif
day
experi
evalu
viral
titer
hematolog
biochemistri
untreat
mice
develop
clinic
biochem
sign
altmax
iul
acut
viral
hepat
die
day
post
infect
fig
tabl
contrast
surviv
enhanc
hrc
mice
fig
associ
increas
surviv
reduct
liver
necrosi
indic
decreas
level
liver
alt
altmax
iul
ribavirin
iul
hrc
tabl
liver
assay
determin
viral
titer
day
viral
titer
risen
minim
detect
limit
assay
although
signific
differ
group
observ
fig
day
mice
die
measur
viral
titer
liver
hrc
mice
day
demonstr
reduct
viral
replic
hrc
anim
compar
ribavirin
group
fig
composit
clinic
score
fig
obtain
combin
clinic
score
measur
symptom
mice
observ
symptom
abnorm
fur
textur
fig
respir
fig
tremor
fig
case
mice
observ
sever
symptom
ribavirin
hrc
therapi
improv
clinic
score
mice
howev
day
hrc
therapi
improv
clinic
score
greater
degre
ribavirin
alon
clinic
mice
treat
ribavirin
develop
clinic
symptom
compat
drug
toxic
ongo
viral
infect
contrast
hrc
mice
maintain
improv
score
behavior
categori
end
studi
fig
hematocrit
hemoglobin
level
tabl
measur
assess
effect
hrc
known
hemolyt
toxic
hemoglobin
level
hrc
mice
greater
control
uninfect
mice
suggest
dose
hb
form
hrc
contribut
significantli
total
blood
hb
concentr
hrc
administr
provid
addit
mg
hb
daili
provid
modest
increas
total
hb
base
total
hb
concentr
gl
control
untreat
mice
hb
level
hrc
mice
statist
higher
mice
p
statist
differ
uninfect
control
mice
untreat
mice
day
onward
tabl
suggest
decreas
blood
total
hb
hematocrit
mice
cours
studi
addit
level
blood
urea
nitrogen
higher
bicarbon
level
lower
significantli
lower
mice
compar
hrc
mice
suggest
ribavirin
treatment
result
disturb
metabol
function
mice
collect
data
suggest
conjug
ribavirin
carrier
protein
hemoglobin
reduc
system
toxic
associ
free
ribavirin
addit
improv
overal
surviv
clinic
behavior
ribavirin
hrc
reduc
histolog
sign
associ
infect
liver
remov
examin
histolog
evid
necrosi
fibrin
deposit
fig
liver
recov
mice
show
greater
necrosi
day
contrast
ribavirin
hrc
infect
mice
show
mark
reduct
histolog
evid
hepat
necrosi
maximum
level
hepat
necrosi
fig
intens
immunostain
fibrin
significantli
reduc
section
liver
hrc
mice
fig
histolog
grade
liver
section
variou
treatment
group
illustr
greatest
intens
fibrin
stain
observ
mice
day
infect
fig
intens
correl
intens
observ
clinic
symptom
fig
contrast
liver
mice
neg
sign
necrosi
fibrosi
although
complet
free
diseas
liver
mice
show
signific
decreas
hepat
necrosi
fibrin
deposit
compar
mice
fig
ribavirin
use
combin
interferon
treatment
acut
chronic
hepat
c
howev
effect
limit
hemolyt
toxic
requir
dose
reduct
discontinu
portion
treatment
renal
clearanc
need
maintain
sustain
virolog
respons
svr
larg
daili
dose
ribavirin
necessari
sustain
benefici
investig
efficaci
target
form
ribavirin
hrc
murin
hepat
viru
strain
assess
benefit
ribavirin
compar
free
ribavirin
caus
spectrum
liver
diseas
mice
includ
fulmin
hepat
liver
failur
vitro
vivo
experi
report
show
hrc
effect
infect
higher
dose
free
ribavirin
result
vitro
experi
macrophag
support
use
hemoglobin
target
drug
therapi
vivo
viral
replic
macrophag
prerequisit
gain
access
liver
parenchym
cell
replic
reduc
macrophag
treat
hrc
contrast
macrophag
treat
approxim
higher
dose
free
ribavirin
effect
due
drug
toxic
macrophag
incub
either
hrc
ribavirin
viabl
shown
exclus
trypan
blue
free
ribavirin
produc
improv
viral
titer
compar
reduct
viral
titer
produc
hrc
viral
infect
macrophag
also
activ
immun
cascad
mediat
cytokin
product
cytokin
includ
increas
macrophag
compar
uninfect
deliveri
hrc
macrophag
via
receptor
allow
direct
target
therapeut
import
member
innat
immun
system
recent
studi
demonstr
increas
express
liver
patient
acut
hepat
compar
chronic
hepat
increas
presenc
attribut
increas
number
activ
macrophag
liver
affect
benefit
target
macrophag
support
demonstr
significantli
greater
reduct
viral
titer
compar
reduct
product
cytokin
use
lower
dose
drug
conjug
form
compar
free
drug
result
present
studi
also
demonstr
enhanc
antivir
activ
hrc
isol
mous
hepatocyt
infect
viru
free
ribavirin
ineffect
reduc
viral
replic
dose
contrast
hepatocyt
incub
concentr
drug
form
hrc
signific
reduct
viral
replic
observ
dose
hrc
requir
inhibit
viral
replic
micromolar
isol
hepatocyt
wherea
similar
viral
inhibit
cultur
macrophag
concentr
ribavirin
requir
even
concentr
signific
inhibit
viral
growth
seen
isol
hepatocyt
wherea
macrophag
concentr
inhibit
explan
find
differ
bind
drug
intracellular
process
rate
degrad
compound
could
account
differ
releas
ribavirin
monophosph
might
explain
enhanc
activ
hepatocyt
howev
ribavirin
releas
hrc
shown
free
ribavirin
monophosphoryl
hrc
also
inhibit
viral
cytopath
effect
syncytia
format
wherea
free
ribavirin
effect
specif
hrc
neither
complex
alon
conjug
alon
inhibitori
data
shown
taken
togeth
find
suggest
process
underli
improv
activ
hrc
compar
free
drug
although
express
hepatocyt
hemoglobin
shown
bind
hepatocyt
fashion
although
hepatocyt
receptor
effect
hrc
also
compar
free
ribavirin
vivo
model
viral
hepat
control
mice
die
within
day
infect
massiv
liver
necrosi
hrc
free
ribavirin
improv
surviv
compar
untreat
control
hrc
treat
mice
exhibit
improv
clinic
behavior
wherea
mice
receiv
free
ribavirin
show
symptom
consist
drug
toxic
ongo
viral
infect
despit
better
histolog
free
ribavirin
group
addit
hrc
maintain
hematocrit
valu
near
baselin
compar
decreas
hematocrit
observ
free
ribavirin
group
hemolyt
effect
ribavirin
normal
occur
week
daili
dose
whether
appar
avoid
effect
mice
directli
relat
known
toxic
ribavirin
unknown
nevertheless
although
exact
mechan
benefici
effect
hrc
known
data
present
suggest
coupl
ribavirin
hemoglobin
improv
safeti
efficaci
ribavirin
target
deliveri
ribavirin
infect
cell
day
infect
hrc
mice
aliv
howev
liver
harvest
mice
treat
hrc
significantli
lower
viral
titer
liver
mice
treat
approxim
free
ribavirin
data
vitro
experi
suggest
overal
decreas
liver
viral
titer
like
attribut
decreas
viral
titer
macrophag
hepatocyt
respons
hrc
hemoglobin
thu
serv
natur
drug
carrier
target
therapi
cell
product
cytokin
markedli
reduc
ribavirin
hrc
macrophag
vitro
fibrin
deposit
liver
respons
activ
immun
coagul
system
involv
mediat
shown
involv
immun
respons
hcv
fibrosi
murin
model
overexpress
induc
sever
liver
liver
harvest
mice
treat
ribavirin
hrc
demonstr
significantli
lower
level
fibrin
deposit
necrosi
compar
mice
therefor
reduct
cytokin
product
like
contribut
overal
improv
liver
histolog
overal
effect
hrc
infect
vivo
demonstr
conjug
target
deliveri
ribavirin
form
hrc
produc
enhanc
activ
signific
improv
aspect
respons
infect
compar
untreat
infect
mice
provid
respons
compar
better
higher
dose
free
drug
combin
vitro
find
result
present
provid
import
effect
hrc
target
drug
agent
use
hemoglobin
collect
result
suggest
target
ribavirin
may
allow
enhanc
clinic
virolog
benefit
set
stage
clinic
trial
design
treat
patient
infect
hepat
c
although
result
present
suggest
identif
new
form
therapi
chronic
hepat
c
data
suggest
target
deliveri
ribavirin
macrophag
hepatocyt
reduc
mani
system
side
effect
produc
free
ribavirin
therefor
sustain
hrc
therapi
could
potenti
allevi
system
side
effect
hemolyt
anemia
normal
result
prematur
cessat
ribavirin
therapi
undertook
studi
examin
potenti
benefit
ribavirin
compound
hrc
prevent
amelior
liver
injuri
caus
murin
hepat
viru
strain
shown
hrc
effect
infect
caus
spectrum
liver
diseas
mice
includ
fulmin
hepat
liver
failur
also
found
mark
effect
hrc
macrophag
presum
mediat
uptak
effect
appear
relat
directli
amelior
liver
injuri
infect
mice
experi
perform
provid
evid
hrc
compound
biochem
histolog
efficaci
amelior
liver
injuri
caus
